These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31923197)

  • 21. Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program.
    Jakubowski A; Lu T; DiRenno F; Jadow B; Giovanniello A; Nahvi S; Cunningham C; Fox A
    J Subst Abuse Treat; 2020 Dec; 119():108140. PubMed ID: 33138925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant use of buprenorphine for medication-assisted treatment of opioid use disorder and benzodiazepines: Using the prescription behavior surveillance system.
    Zhu Y; Coyle DT; Mohamoud M; Zhou E; Eworuke E; Dormitzer C; Staffa J
    Drug Alcohol Depend; 2018 Jun; 187():221-226. PubMed ID: 29680678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral buprenorphine utilization, concomitant benzodiazepines and opioid analgesics, and payment source: Trends from 2015 to 2019.
    Ijioma SC; Chilcoat HD; DeVeaugh-Geiss AM
    J Subst Use Addict Treat; 2023 Apr; 147():208980. PubMed ID: 36841074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
    Ling S; Mangaoil R; Cleverley K; Sproule B; Puts M
    Drug Alcohol Depend; 2019 Apr; 197():168-182. PubMed ID: 30831429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
    Fishman MJ; Wu LT; Woody GE
    Am J Psychiatry; 2011 Jul; 168(7):675-9. PubMed ID: 21724673
    [No Abstract]   [Full Text] [Related]  

  • 27. Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population.
    Hallowell BD; Chambers LC; Samuels EA; Bratberg J; McDonald J; Nitenson A; Onyejekwe C; Beaudoin FL
    Drug Alcohol Depend; 2022 Dec; 241():109680. PubMed ID: 36335834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression and Buprenorphine Treatment in Patients with Non-cancer Pain and Prescription Opioid Dependence without Comorbid Substance Use Disorders.
    Scherrer JF; Salas J; Grucza R; Sullivan MD; Lustman PJ; Copeland LA; Ballantyne JC
    J Affect Disord; 2021 Jan; 278():563-569. PubMed ID: 33022442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
    Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Buprenorphine utilization among all Washington State residents' based upon prescription monitoring program data - Characteristics associated with two measures of retention and patterns of care over time.
    Banta-Green CJ; Hansen RN; Ossiander EM; Wasserman CR; Merrill JO
    J Subst Abuse Treat; 2021 Aug; 127():108446. PubMed ID: 34049724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records.
    Macleod J; Steer C; Tilling K; Cornish R; Marsden J; Millar T; Strang J; Hickman M
    PLoS Med; 2019 Nov; 16(11):e1002965. PubMed ID: 31770388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-buprenorphine opioid utilization among patients using buprenorphine.
    Daubresse M; Saloner B; Pollack HA; Alexander GC
    Addiction; 2017 Jun; 112(6):1045-1053. PubMed ID: 28107580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.
    Oliveira C; Filipe R; Meira J; Sampaio L; Teixeira L; Rodrigues J; Nunes I; Tavares J
    Acta Med Port; 2021 Mar; 34(3):209-216. PubMed ID: 33971116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.
    Wiegand TJ
    J Med Toxicol; 2016 Mar; 12(1):64-70. PubMed ID: 26574020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine prescribing and treatment accessibility in response to regulation changes due to the COVID-19 public health emergency.
    Paiva TJ; Wightman RS; St John K; Nitenson AZ; Onyejekwe C; Hallowell BD
    J Subst Use Addict Treat; 2024 Jul; 162():209382. PubMed ID: 38677597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017.
    Luu H; Slavova S; Freeman PR; Lofwall M; Browning S; Slade E; Bush H
    Drug Alcohol Depend; 2019 Dec; 205():107606. PubMed ID: 31606590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes.
    Nguyen B; Zhao C; Bailly E; Chi W
    J Gen Intern Med; 2024 Jan; 39(1):95-102. PubMed ID: 37670069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.